Brian L. Egleston, Ph.D. - Publications

2006 Johns Hopkins University, Baltimore, MD 
Statistics, Ophthalmology, Public Health, Biostatistics Biology

102 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Churilla TM, Egleston BL, Murphy CT, Sigurdson ER, Hayes SB, Goldstein LJ, Bleicher RJ. Patterns of multidisciplinary care in the management of non-metastatic invasive breast cancer in the United States Medicare patient. Breast Cancer Research and Treatment. PMID 27640196 DOI: 10.1007/s10549-016-3982-x  0.6
2016 Meeker CR, Geynisman DM, Egleston BL, Hall MJ, Mechanic KY, Bilusic M, Plimack ER, Martin LP, von Mehren M, Lewis B, Wong YN. Relationships Among Financial Distress, Emotional Distress, and Overall Distress in Insured Patients With Cancer. Journal of Oncology Practice / American Society of Clinical Oncology. PMID 27328795 DOI: 10.1200/JOP.2016.011049  0.6
2016 Zaorsky NG, Egleston BL, Horwitz EM, Dicker AP, Nguyen PL, Showalter TN, Den RB. The Missing Pieces in Reporting of Randomized Controlled Trials of External Beam Radiation Therapy Dose Escalation for Prostate Cancer. American Journal of Clinical Oncology. PMID 27322694 DOI: 10.1097/COC.0000000000000313  0.6
2016 Kudinov AE, Deneka A, Nikonova AS, Beck TN, Ahn YH, Liu X, Martinez CF, Schultz FA, Reynolds S, Yang DH, Cai KQ, Yaghmour KM, Baker KA, Egleston BL, Nicolas E, et al. Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis. Proceedings of the National Academy of Sciences of the United States of America. PMID 27274057 DOI: 10.1073/pnas.1513616113  0.6
2016 Murphy CT, Galloway TJ, Handorf EA, Egleston BL, Ridge JA. Reply to P. Blanchard et al. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27114603 DOI: 10.1200/JCO.2016.67.2832  0.6
2015 Murphy CT, Galloway TJ, Handorf EA, Egleston BL, Wang LS, Mehra R, Flieder DB, Ridge JA. Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26628469 DOI: 10.1200/JCO.2015.61.5906  0.6
2015 Nikonova AS, Deneka AY, Eckman L, Kopp MC, Hensley HH, Egleston BL, Golemis EA. Opposing Effects of Inhibitors of Aurora-A and EGFR in Autosomal-Dominant Polycystic Kidney Disease. Frontiers in Oncology. 5: 228. PMID 26528438 DOI: 10.3389/fonc.2015.00228  0.6
2015 Nicolas E, Arora S, Zhou Y, Serebriiskii IG, Andrake MD, Handorf ED, Bodian DL, Vockley JG, Dunbrack RL, Ross EA, Ealeston B, Hall MJ, Golemis EA, Giri VN, Daly MB. Systematic evaluation of underlying defects in DNA repair as an approach to case-only assessment of familial prostate cancer. Oncotarget. PMID 26485759 DOI: 10.18632/oncotarget.5554  0.6
2015 Bleicher RJ, Ruth K, Sigurdson ER, Daly JM, Boraas M, Anderson PR, Egleston BL. Breast conservation versus mastectomy for patients with T3 primary tumors (>5 cm) a review of 5685 medicare patients. Cancer. PMID 26479066 DOI: 10.1002/cncr.29726  0.6
2015 Arora S, Yan H, Cho I, Fan HY, Luo B, Gai X, Bodian DL, Vockley JG, Zhou Y, Handorf E, Egleston BL, Andrake M, Nicolas E, Serebriiskii I, Yen TJ, et al. Genetic Variants That Presdispose to DNA Double-strand Breaks in Lymphocytes from a Subset of Patients With Familial Colorectal Carcinomas. Gastroenterology. PMID 26344056 DOI: 10.1053/j.gastro.2015.08.052  0.6
2015 Egleston BL, Pedraza O, Wong YN, Dunbrack RL, Griffin CL, Ross EA, Beck JR. Characteristics of clinical trials that require participants to be fluent in English. Clinical Trials (London, England). PMID 26152834 DOI: 10.1177/1740774515592881  0.6
2015 Jung S, Egleston BL, Chandler DW, Van Horn L, Hylton NM, Klifa CC, Lasser NL, LeBlanc ES, Paris K, Shepherd JA, Snetselaar LG, Stanczyk FZ, Stevens VJ, Dorgan JF. Adolescent endogenous sex hormones and breast density in early adulthood. Breast Cancer Research : Bcr. 17: 77. PMID 26041651 DOI: 10.1186/s13058-015-0581-4  0.6
2015 Bradbury AR, Patrick-Miller LJ, Egleston BL, DiGiovanni L, Brower J, Harris D, Stevens EM, Maxwell KN, Kulkarni A, Chavez T, Brandt A, Long JM, Powers J, Stopfer JE, Nathanson KL, et al. Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 25834950 DOI: 10.1038/gim.2015.19  0.6
2015 Jung S, Stanczyk FZ, Egleston BL, Snetselaar LG, Stevens VJ, Shepherd JA, Van Horn L, LeBlanc ES, Paris K, Klifa C, Dorgan JF. Endogenous Sex Hormones and Breast Density in Young Women Cancer Epidemiology Biomarkers and Prevention. 24: 369-378. DOI: 10.1158/1055-9965.EPI-14-0939  0.6
2014 Egleston BL, Uzzo RG, Beck JR, Wong Y. A Simple Method for Evaluating Within-Sample Prognostic Balance Achieved by Published Comorbidity Summary Measures. Health Services Research. PMID 25523400 DOI: 10.1111/1475-6773.12276  0.6
2014 Smithline ZB, Nikonova AS, Hensley HH, Cai KQ, Egleston BL, Proia DA, Seeger-Nukpezah T, Golemis EA. Inhibiting heat shock protein 90 (HSP90) limits the formation of liver cysts induced by conditional deletion of Pkd1 in mice. Plos One. 9: e114403. PMID 25474361 DOI: 10.1371/journal.pone.0114403  0.6
2014 Nikonova AS, Plotnikova OV, Serzhanova V, Efimov A, Bogush I, Cai KQ, Hensley HH, Egleston BL, Klein-Szanto A, Seeger-Nukpezah T, Golemis EA. Nedd9 restrains renal cystogenesis in Pkd1-/- mice. Proceedings of the National Academy of Sciences of the United States of America. 111: 12859-64. PMID 25139996 DOI: 10.1073/pnas.1405362111  0.6
2014 Doss M, Egleston BL, Litwin S. Atomic bomb survivor cataract surgery prevalence data are consistent with non-zero threshold dose--Comment on article by Nakashima et al. 2013. Health Physics. 107: 262-3. PMID 25068966 DOI: 10.1097/HP.0000000000000137  0.6
2014 Silverman D, Ruth K, Sigurdson ER, Egleston BL, Goldstein LJ, Wong YN, Boraas M, Bleicher RJ. Skin involvement and breast cancer: are T4b lesions of all sizes created equal? Journal of the American College of Surgeons. 219: 534-44. PMID 25026875 DOI: 10.1016/j.jamcollsurg.2014.04.003  0.6
2014 Beeharry N, Banina E, Hittle J, Skobeleva N, Khazak V, Deacon S, Andrake M, Egleston BL, Peterson JR, Astsaturov I, Yen TJ. Re-purposing clinical kinase inhibitors to enhance chemosensitivity by overriding checkpoints. Cell Cycle (Georgetown, Tex.). 13: 2172-91. PMID 24955955 DOI: 10.4161/cc.29214  0.6
2014 Fang CY, Egleston BL, Manzur AM, Townsend RR, Stanczyk FZ, Spiegel D, Dorgan JF. Psychological reactivity to laboratory stress is associated with hormonal responses in postmenopausal women Journal of International Medical Research. 42: 444-456. PMID 24595153 DOI: 10.1177/0300060513504696  0.6
2014 Loveland-Jones CE, Ruth K, Sigurdson ER, Egleston BL, Boraas M, Bleicher RJ. Patterns of nodal staging during breast conservation surgery in the medicare patient: will the ACOSOG Z0011 trial change the pattern of care? Breast Cancer Research and Treatment. 143: 571-7. PMID 24442687 DOI: 10.1007/s10549-014-2834-9  0.6
2014 Simhan J, Smaldone MC, Egleston BL, Canter D, Sterious SN, Corcoran AT, Ginzburg S, Uzzo RG, Kutikov A. Nephron-sparing management vs radical nephroureterectomy for low- or moderate-grade, low-stage upper tract urothelial carcinoma. Bju International. 114: 216-20. PMID 24053485 DOI: 10.1111/bju.12341  0.6
2014 Fang CY, Egleston BL, Ridge JA, Lango MN, Bovbjerg DH, Studts JL, Burtness BA, Einarson MB, Klein-Szanto AJ. Psychosocial functioning and vascular endothelial growth factor in patients with head and neck cancer. Head & Neck. 36: 1113-9. PMID 23804308 DOI: 10.1002/hed.23421  0.6
2014 Little JL, Serzhanova V, Izumchenko E, Egleston BL, Parise E, Klein-Szanto AJ, Loudon G, Shubina M, Seo S, Kurokawa M, Ochs MF, Golemis EA. A requirement for Nedd9 in luminal progenitor cells prior to mammary tumorigenesis in MMTV-HER2/ErbB2 mice. Oncogene. 33: 411-20. PMID 23318423 DOI: 10.1038/onc.2012.607  0.6
2013 Patrick-Miller L, Egleston BL, Daly M, Stevens E, Fetzer D, Forman A, Bealin L, Rybak C, Peterson C, Corbman M, Bradbury AR. Implementation and outcomes of telephone disclosure of clinical BRCA1/2 test results. Patient Education and Counseling. 93: 413-9. PMID 24075727 DOI: 10.1016/j.pec.2013.08.009  0.6
2013 Stump TK, Eghan N, Egleston BL, Hamilton O, Pirollo M, Schwartz JS, Armstrong K, Beck JR, Meropol NJ, Wong YN. Cost concerns of patients with cancer. Journal of Oncology Practice / American Society of Clinical Oncology. 9: 251-7. PMID 23943901 DOI: 10.1200/JOP.2013.000929  0.6
2013 Dorgan JF, Klifa C, Deshmukh S, Egleston BL, Shepherd JA, Kwiterovich PO, Van Horn L, Snetselaar LG, Stevens VJ, Robson AM, Lasser NL, Hylton NM. Menstrual and reproductive characteristics and breast density in young women. Cancer Causes & Control : Ccc. 24: 1973-83. PMID 23933948 DOI: 10.1007/s10552-013-0273-2  0.6
2013 Wong YN, Egleston BL, Sachdeva K, Eghan N, Pirollo M, Stump TK, Beck JR, Armstrong K, Schwartz JS, Meropol NJ. Cancer patients' trade-offs among efficacy, toxicity, and out-of-pocket cost in the curative and noncurative setting. Medical Care. 51: 838-45. PMID 23872905 DOI: 10.1097/MLR.0b013e31829faffd  0.6
2013 Seeger-Nukpezah T, Proia DA, Egleston BL, Nikonova AS, Kent T, Cai KQ, Hensley HH, Ying W, Chimmanamada D, Serebriiskii IG, Golemis EA. Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease. Proceedings of the National Academy of Sciences of the United States of America. 110: 12786-91. PMID 23858461 DOI: 10.1073/pnas.1301904110  0.6
2013 Corcoran AT, Smaldone MC, Egleston BL, Simhan J, Ginzburg S, Morgan TM, Walton J, Chen DY, Viterbo R, Greenberg RE, Uzzo RG, Kutikov A. Comparison of prostate cancer diagnosis in patients receiving unrelated urological and non-urological cancer care. Bju International. 112: 161-8. PMID 23795784 DOI: 10.1111/bju.12220  0.6
2013 Moy B, Bradbury AR, Helft PR, Egleston BL, Sheikh-Salah M, Peppercorn J. Correlation between financial relationships with commercial interests and research prominence at an oncology meeting. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 2678-84. PMID 23775973 DOI: 10.1200/JCO.2012.46.6375  0.6
2013 Austin SR, Wong YN, Uzzo RG, Beck JR, Egleston BL. Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work. Medical Care. PMID 23703645 DOI: 10.1097/MLR.0b013e318297429c  0.6
2013 Montgomery SV, Barsevick AM, Egleston BL, Bingler R, Ruth K, Miller SM, Malick J, Cescon TP, Daly MB. Preparing individuals to communicate genetic test results to their relatives: report of a randomized control trial. Familial Cancer. 12: 537-46. PMID 23420550 DOI: 10.1007/s10689-013-9609-z  0.6
2013 Giordano A, Egleston BL, Hajage D, Bland J, Hortobagyi GN, Reuben JM, Pierga JY, Cristofanilli M, Bidard FC. Establishment and validation of circulating tumor cell-based prognostic nomograms in first-line metastatic breast cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 1596-602. PMID 23340302 DOI: 10.1158/1078-0432.CCR-12-3137  0.6
2013 Meropol NJ, Egleston BL, Buzaglo JS, Balshem A, Benson AB, Cegala DJ, Cohen RB, Collins M, Diefenbach MA, Miller SM, Fleisher L, Millard JL, Ross EA, Schulman KA, Silver A, et al. A Web-based communication aid for patients with cancer: the CONNECT Study. Cancer. 119: 1437-45. PMID 23335150 DOI: 10.1002/cncr.27874  0.6
2013 Sukhanova A, Gorin A, Serebriiskii IG, Gabitova L, Zheng H, Restifo D, Egleston BL, Cunningham D, Bagnyukova T, Liu H, Nikonova A, Adams GP, Zhou Y, Yang DH, Mehra R, et al. Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation. Cancer Discovery. 3: 96-111. PMID 23125191 DOI: 10.1158/2159-8290.CD-12-0031  0.6
2013 Stoyanova R, Pahlajani NH, Egleston BL, Buyyounouski MK, Chen DY, Horwitz EM, Pollack A. The impact of dose-escalated radiotherapy plus androgen deprivation for prostate cancer using 2 linked nomograms. Cancer. 119: 1080-8. PMID 23096533 DOI: 10.1002/cncr.27857  0.6
2013 Van Cleave JH, Egleston BL, Ercolano E, McCorkle R. Symptom distress in older adults following cancer surgery. Cancer Nursing. 36: 292-300. PMID 23047803 DOI: 10.1097/NCC.0b013e31826dd517  0.6
2013 Crivello ML, Ruth K, Sigurdson ER, Egleston BL, Evers K, Wong YN, Boraas M, Bleicher RJ. Advanced imaging modalities in early stage breast cancer: preoperative use in the United States Medicare population. Annals of Surgical Oncology. 20: 102-10. PMID 22878617 DOI: 10.1245/s10434-012-2571-4  0.6
2013 Fang CY, Egleston BL, Gabriel KP, Stevens VJ, Kwiterovich PO, Snetselaar LG, Longacre ML, Dorgan JF. Depressive symptoms and serum lipid levels in young adult women. Journal of Behavioral Medicine. 36: 143-52. PMID 22382824 DOI: 10.1007/s10865-012-9409-1  0.6
2013 Miller SM, Hudson SV, Egleston BL, Manne S, Buzaglo JS, Devarajan K, Fleisher L, Millard J, Solarino N, Trinastic J, Meropol NJ. The relationships among knowledge, self-efficacy, preparedness, decisional conflict, and decisions to participate in a cancer clinical trial Psycho-Oncology. 22: 481-489. PMID 22331643 DOI: 10.1002/pon.3043  0.6
2012 Bleicher RJ, Ruth K, Sigurdson ER, Ross E, Wong YN, Patel SA, Boraas M, Topham NS, Egleston BL. Preoperative delays in the US Medicare population with breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 4485-92. PMID 23169513 DOI: 10.1200/JCO.2012.41.7972  0.6
2012 Kutikov A, Egleston BL, Canter D, Smaldone MC, Wong YN, Uzzo RG. Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based model. The Journal of Urology. 188: 2077-83. PMID 23083850 DOI: 10.1016/j.juro.2012.07.100  0.6
2012 Bradbury AR, Patrick-Miller L, Egleston BL, Schwartz LA, Sands CB, Shorter R, Moore CW, Tuchman L, Rauch P, Malhotra S, Rowan B, Van Decker S, Schmidheiser H, Bealin L, Sicilia P, et al. Knowledge and perceptions of familial and genetic risks for breast cancer risk in adolescent girls. Breast Cancer Research and Treatment. 136: 749-57. PMID 23065030 DOI: 10.1007/s10549-012-2254-7  0.6
2012 Doss M, Egleston BL, Litwin S. Comments on "Studies of the mortality of atomic bomb survivors, report 14, 1950-2003: an overview of cancer and noncancer diseases" (Radiat Res 2012; 177:229-43). Radiation Research. 178: 244-5. PMID 22817395 DOI: 10.1667/RR3039.1  0.6
2012 Dorgan JF, Klifa C, Shepherd JA, Egleston BL, Kwiterovich PO, Himes JH, Gabriel K, Horn L, Snetselaar LG, Stevens VJ, Barton BA, Robson AM, Lasser NL, Deshmukh S, Hylton NM. Height, adiposity and body fat distribution and breast density in young women. Breast Cancer Research : Bcr. 14: R107. PMID 22800711 DOI: 10.1186/bcr3228  0.6
2012 Van Cleave JH, Egleston BL, Bourbonniere M, Cardone L, McCorkle R. Functional status in older women following gynecological cancer surgery: can choice of measure influence evidence for clinical practice? Geriatric Nursing (New York, N.Y.). 33: 118-26. PMID 22387192 DOI: 10.1016/j.gerinurse.2012.01.004  0.6
2012 Bradbury AR, Patrick-Miller L, Egleston BL, Olopade OI, Daly MB, Moore CW, Sands CB, Schmidheiser H, Kondamudi PK, Feigon M, Ibe CN, Daugherty CK. When parents disclose BRCA1/2 test results: their communication and perceptions of offspring response. Cancer. 118: 3417-25. PMID 22231763 DOI: 10.1002/cncr.26471  0.6
2012 Kutikov A, Smaldone MC, Egleston BL, Uzzo RG. Should partial nephrectomy be offered to all patients whenever technically feasible? European Urology. 61: 732-4; discussion 73. PMID 22197441 DOI: 10.1016/j.eururo.2011.12.014  0.6
2012 Kutikov A, Rozenfeld B, Egleston BL, Sirohi M, Hwang RW, Uzzo RG. Academic ranking score: a publication-based reproducible metric of thought leadership in urology. European Urology. 61: 435-9. PMID 22036644 DOI: 10.1016/j.eururo.2011.10.025  0.6
2012 Smaldone MC, Kutikov A, Egleston BL, Canter DJ, Viterbo R, Chen DY, Jewett MA, Greenberg RE, Uzzo RG. Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer. 118: 997-1006. PMID 21766302 DOI: 10.1002/cncr.26369  0.6
2012 Stitzenberg KB, Wong YN, Nielsen ME, Egleston BL, Uzzo RG. Trends in radical prostatectomy: centralization, robotics, and access to urologic cancer care. Cancer. 118: 54-62. PMID 21717436 DOI: 10.1002/cncr.26274  0.6
2011 Egleston BL, Miller SM, Meropol NJ. The impact of misclassification due to survey response fatigue on estimation and identifiability of treatment effects. Statistics in Medicine. 30: 3560-72. PMID 21953305 DOI: 10.1002/sim.4377  0.6
2011 Mustafa A, Gupta S, Hudes GR, Egleston BL, Uzzo RG, Kruger WD. Serum amino acid levels as a biomarker for renal cell carcinoma. The Journal of Urology. 186: 1206-12. PMID 21849193 DOI: 10.1016/j.juro.2011.05.085  0.6
2011 Shaw CM, Stanczyk FZ, Egleston BL, Kahle LL, Spittle CS, Godwin AK, Brinton LA, Dorgan JF. Serum antimüllerian hormone in healthy premenopausal women. Fertility and Sterility. 95: 2718-21. PMID 21704216 DOI: 10.1016/j.fertnstert.2011.05.051  0.6
2011 Egleston BL. Response to Pearl's comments on principal stratification. The International Journal of Biostatistics. 7: 24. PMID 21686084 DOI: 10.2202/1557-4679.1330  0.6
2011 Kutikov A, Smaldone MC, Egleston BL, Manley BJ, Canter DJ, Simhan J, Boorjian SA, Viterbo R, Chen DY, Greenberg RE, Uzzo RG. Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score. European Urology. 60: 241-8. PMID 21458155 DOI: 10.1016/j.eururo.2011.03.029  0.6
2011 Van Cleave JH, Egleston BL, McCorkle R. Factors affecting recovery of functional status in older adults after cancer surgery. Journal of the American Geriatrics Society. 59: 34-43. PMID 21226675 DOI: 10.1111/j.1532-5415.2010.03210.x  0.6
2011 Van Cleave JH, Egleston BL, Bourbonniere M, McCorkle R. Combining extant datasets with differing outcome measures across studies of older adults after cancer surgery. Research in Gerontological Nursing. 4: 36-46. PMID 21210576 DOI: 10.3928/19404921-20101201-02  0.6
2011 Long CJ, Kutikov A, Canter DJ, Egleston BL, Chen DY, Viterbo R, Boorjian SA, Uzzo RG. Percutaneous vs surgical cryoablation of the small renal mass: is efficacy compromised? Bju International. 107: 1376-80. PMID 21062399 DOI: 10.1111/j.1464-410X.2010.09851.x  0.6
2010 Singh MK, Izumchenko E, Klein-Szanto AJ, Egleston BL, Wolfson M, Golemis EA. Enhanced genetic instability and dasatinib sensitivity in mammary tumor cells lacking NEDD9. Cancer Research. 70: 8907-16. PMID 20940402 DOI: 10.1158/0008-5472.CAN-10-0353  0.6
2010 Heckman CJ, Egleston BL, Hofmann MT. Efficacy of motivational interviewing for smoking cessation: a systematic review and meta-analysis. Tobacco Control. 19: 410-6. PMID 20675688 DOI: 10.1136/tc.2009.033175  0.6
2010 Egleston BL, Cropsey KL, Lazev AB, Heckman CJ. A tutorial on principal stratification-based sensitivity analysis: application to smoking cessation studies. Clinical Trials (London, England). 7: 286-98. PMID 20423924 DOI: 10.1177/1740774510367811  0.6
2010 Egleston BL, Chandler DW, Dorgan JF. Validity of estimating non-sex hormone-binding globulin bound testosterone and oestradiol from total hormone measurements in boys and girls. Annals of Clinical Biochemistry. 47: 233-41. PMID 20406780 DOI: 10.1258/acb.2010.009112  0.6
2010 Scott WJ, Matteotti RS, Egleston BL, Oseni S, Flaherty JF. A comparison of perioperative outcomes of video-assisted thoracic surgical (VATS) lobectomy with open thoracotomy and lobectomy: results of an analysis using propensity score based weighting. Annals of Surgical Innovation and Research. 4: 1. PMID 20307297 DOI: 10.1186/1750-1164-4-1  0.6
2010 Egleston BL, Dunbrack RL, Hall MJ. Clinical trials that explicitly exclude gay and lesbian patients. The New England Journal of Medicine. 362: 1054-5. PMID 20237357 DOI: 10.1056/NEJMc0912600  0.6
2010 Kutikov A, Egleston BL, Wong YN, Uzzo RG. Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 311-7. PMID 19933918 DOI: 10.1200/JCO.2009.22.4816  0.6
2010 Kutikov A, Uzzo RG, Caraway A, Reese CT, Egleston BL, Chen DY, Viterbo R, Greenberg RE, Wong YN, Raman JD, Boorjian SA. Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomy. Bju International. 106: 218-23. PMID 19922542 DOI: 10.1111/j.1464-410X.2009.09079.x  0.6
2010 Wang C, Miller SM, Egleston BL, Hay JL, Weinberg DS. Beliefs about the causes of breast and colorectal cancer among women in the general population. Cancer Causes & Control : Ccc. 21: 99-107. PMID 19787437 DOI: 10.1007/s10552-009-9439-3  0.6
2010 Kaplan DJ, Boorjian SA, Ruth K, Egleston BL, Chen DY, Viterbo R, Uzzo RG, Buyyounouski MK, Raysor S, Giri VN. Evaluation of the Prostate Cancer Prevention Trial Risk calculator in a high-risk screening population. Bju International. 105: 334-7. PMID 19709072 DOI: 10.1111/j.1464-410X.2009.08793.x  0.6
2010 Dorgan JF, Spittle CS, Egleston BL, Shaw CM, Kahle LL, Brinton LA. Assay reproducibility and within-person variation of Müllerian inhibiting substance. Fertility and Sterility. 94: 301-4. PMID 19409547 DOI: 10.1016/j.fertnstert.2009.03.032  0.6
2010 Kutikov A, Egleston BL, Wong YN, Uzzo RG. Reply to J. Lagro et al and G. Lughezzani et al Journal of Clinical Oncology. 28. DOI: 10.1200/JCO.2010.28.0347  0.6
2009 Kurland BF, Johnson LL, Egleston BL, Diehr PH. Longitudinal Data with Follow-up Truncated by Death: Match the Analysis Method to Research Aims. Statistical Science : a Review Journal of the Institute of Mathematical Statistics. 24: 211. PMID 20119502 DOI: 10.1214/09-STS293  0.6
2009 Vig HS, Armstrong J, Egleston BL, Mazar C, Toscano M, Bradbury AR, Daly MB, Meropol NJ. Cancer genetic risk assessment and referral patterns in primary care. Genetic Testing and Molecular Biomarkers. 13: 735-41. PMID 20001580 DOI: 10.1089/gtmb.2009.0037  0.6
2009 Egleston BL, Meireles SI, Flieder DB, Clapper ML. Population-based trends in lung cancer incidence in women. Seminars in Oncology. 36: 506-15. PMID 19995642 DOI: 10.1053/j.seminoncol.2009.09.003  0.6
2009 Dorgan JF, Stanczyk FZ, Egleston BL, Kahle LL, Shaw CM, Spittle CS, Godwin AK, Brinton LA. Prospective case-control study of serum mullerian inhibiting substance and breast cancer risk. Journal of the National Cancer Institute. 101: 1501-9. PMID 19820206 DOI: 10.1093/jnci/djp331  0.6
2009 Izumchenko E, Singh MK, Plotnikova OV, Tikhmyanova N, Little JL, Serebriiskii IG, Seo S, Kurokawa M, Egleston BL, Klein-Szanto A, Pugacheva EN, Hardy RR, Wolfson M, Connolly DC, Golemis EA. NEDD9 promotes oncogenic signaling in mammary tumor development. Cancer Research. 69: 7198-206. PMID 19738060 DOI: 10.1158/0008-5472.CAN-09-0795  0.6
2009 Stitzenberg KB, Sigurdson ER, Egleston BL, Starkey RB, Meropol NJ. Centralization of cancer surgery: implications for patient access to optimal care. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 4671-8. PMID 19720926 DOI: 10.1200/JCO.2008.20.1715  0.6
2009 Bleicher RJ, Ciocca RM, Egleston BL, Sesa L, Evers K, Sigurdson ER, Morrow M. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. Journal of the American College of Surgeons. 209: 180-7; quiz 294-5. PMID 19632594 DOI: 10.1016/j.jamcollsurg.2009.04.010  0.6
2009 Fang CY, Egleston BL, Brown KM, Lavigne JV, Stevens VJ, Barton BA, Chandler DW, Dorgan JF. Family cohesion moderates the relation between free testosterone and delinquent behaviors in adolescent boys and girls. The Journal of Adolescent Health : Official Publication of the Society For Adolescent Medicine. 44: 590-7. PMID 19465324 DOI: 10.1016/j.jadohealth.2008.11.018  0.6
2009 Coups EJ, Park BJ, Feinstein MB, Steingart RM, Egleston BL, Wilson DJ, Ostroff JS. Correlates of physical activity among lung cancer survivors. Psycho-Oncology. 18: 395-404. PMID 19241488 DOI: 10.1002/pon.1520  0.6
2009 Egleston BL, Wong YN. Sensitivity analysis to investigate the impact of a missing covariate on survival analyses using cancer registry data. Statistics in Medicine. 28: 1498-511. PMID 19235263 DOI: 10.1002/sim.3557  0.6
2009 Coups EJ, Park BJ, Feinstein MB, Steingart RM, Egleston BL, Wilson DJ, Ostroff JS. Physical activity among lung cancer survivors: changes across the cancer trajectory and associations with quality of life. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 664-72. PMID 19190151 DOI: 10.1158/1055-9965.EPI-08-0589  0.6
2009 Scoll BJ, Wong YN, Egleston BL, Kunkle DA, Saad IR, Uzzo RG. Age, tumor size and relative survival of patients with localized renal cell carcinoma: a surveillance, epidemiology and end results analysis. The Journal of Urology. 181: 506-11. PMID 19084868 DOI: 10.1016/j.juro.2008.10.026  0.6
2009 Egleston BL, Scharfstein DO, MacKenzie E. On estimation of the survivor average causal effect in observational studies when important confounders are missing due to death. Biometrics. 65: 497-504. PMID 18759833 DOI: 10.1111/j.1541-0420.2008.01111.x  0.6
2008 Meropol NJ, Egleston BL, Buzaglo JS, Benson AB, Cegala DJ, Diefenbach MA, Fleisher L, Miller SM, Sulmasy DP, Weinfurt KP. Cancer patient preferences for quality and length of life. Cancer. 113: 3459-66. PMID 18988231 DOI: 10.1002/cncr.23968  0.6
2008 Fleisher L, Buzaglo J, Collins M, Millard J, Miller SM, Egleston BL, Solarino N, Trinastic J, Cegala DJ, Benson AB, Schulman KA, Weinfurt KP, Sulmasy D, Diefenbach MA, Meropol NJ. Using health communication best practices to develop a web-based provider-patient communication aid: the CONNECT study. Patient Education and Counseling. 71: 378-87. PMID 18417312 DOI: 10.1016/j.pec.2008.02.017  0.6
2008 Barsevick AM, Montgomery SV, Ruth K, Ross EA, Egleston BL, Bingler R, Malick J, Miller SM, Cescon TP, Daly MB. Intention to communicate BRCA1/BRCA2 genetic test results to the family. Journal of Family Psychology : Jfp : Journal of the Division of Family Psychology of the American Psychological Association (Division 43). 22: 303-12. PMID 18410217 DOI: 10.1037/0893-3200.22.2.303  0.6
2008 Kunkle DA, Egleston BL, Uzzo RG. Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review. The Journal of Urology. 179: 1227-33; discussion . PMID 18280512 DOI: 10.1016/j.juro.2007.11.047  0.6
2008 Singh MK, Dadke D, Nicolas E, Serebriiskii IG, Apostolou S, Canutescu A, Egleston BL, Golemis EA. A novel Cas family member, HEPL, regulates FAK and cell spreading. Molecular Biology of the Cell. 19: 1627-36. PMID 18256281 DOI: 10.1091/mbc.E07-09-0953  0.6
2008 Heckman CJ, Egleston BL, Wilson DB, Ingersoll KS. A preliminary investigation of the predictors of tanning dependence. American Journal of Health Behavior. 32: 451-64. PMID 18241130 DOI: 10.5555/ajhb.2008.32.5.451  0.6
2008 Mackenzie EJ, Rivara FP, Jurkovich GJ, Nathens AB, Egleston BL, Salkever DS, Frey KP, Scharfstein DO. The impact of trauma-center care on functional outcomes following major lower-limb trauma. The Journal of Bone and Joint Surgery. American Volume. 90: 101-9. PMID 18171963 DOI: 10.2106/JBJS.F.01225  0.6
2007 Mackenzie EJ, Rivara FP, Jurkovich GJ, Nathens AB, Frey KP, Egleston BL, Salkever DS, Weir S, Scharfstein DO. The National Study on Costs and Outcomes of Trauma. The Journal of Trauma. 63: S54-67; discussion S. PMID 18091213 DOI: 10.1097/TA.0b013e31815acb09  0.6
2007 Yu Z, Weinberger PM, Sasaki C, Egleston BL, Speier WF, Haffty B, Kowalski D, Camp R, Rimm D, Vairaktaris E, Burtness B, Psyrri A. Phosphorylation of Akt (Ser473) predicts poor clinical outcome in oropharyngeal squamous cell cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 553-8. PMID 17372251 DOI: 10.1158/1055-9965.EPI-06-0121  0.6
2007 Egleston BL, Scharfstein DO, Freeman EE, West SK. Causal inference for non-mortality outcomes in the presence of death. Biostatistics (Oxford, England). 8: 526-45. PMID 16980696 DOI: 10.1093/biostatistics/kxl027  0.6
2006 MacKenzie EJ, Rivara FP, Jurkovich GJ, Nathens AB, Frey KP, Egleston BL, Salkever DS, Scharfstein DO. A national evaluation of the effect of trauma-center care on mortality. The New England Journal of Medicine. 354: 366-78. PMID 16436768 DOI: 10.1056/NEJMsa052049  0.6
2005 Freeman EE, Egleston BL, West SK, Bandeen-Roche K, Rubin G. Visual acuity change and mortality in older adults. Investigative Ophthalmology & Visual Science. 46: 4040-5. PMID 16249478 DOI: 10.1167/iovs.05-0687  0.6
2000 Egleston BL, Rudberg MA, Brody JA. State variation in nursing home mortality outcomes according to do-not- resuscitate status Journals of Gerontology - Series a Biological Sciences and Medical Sciences. 55. PMID 10811151  0.6
2000 Rudberg MA, Egleston BL, Grant MD, Brody JA. Effectiveness of feeding tubes in nursing home residents with swallowing disorders Journal of Parenteral and Enteral Nutrition. 24: 97-102. PMID 10772189  0.6
1999 Egleston BL, Rudberg MA, Brody JA. Prior living arrangements and nursing home resident admission ADL characteristics: A study of two states Journals of Gerontology - Series B Psychological Sciences and Social Sciences. 54. PMID 12382598  0.6
1999 Suri DN, Egleston BL, Brody JA, Rudberg MA. Nursing home resident use of care directives Journals of Gerontology - Series a Biological Sciences and Medical Sciences. 54. PMID 10362004  0.6
Show low-probability matches.